Implications to payers of switch from hospital-based intravenous immunoglobulin to home-based subcutaneous immunoglobulin therapy in patients with primary and secondary immunodeficiencies in Canada

BACKGROUND: Switching primary/secondary immunodeficiency (PID/SID) patients from intravenous immunoglobulin (IVIg) to home-based subcutaneous immunoglobulin (SCIg) therapy reduces nurse time. A nurse shortage in Canada provides an important context to estimate the net economic benefit, the number of...

Descripción completa

Detalles Bibliográficos
Autores principales: Gerth, William C, Betschel, Stephen D, Zbrozek, Arthur S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Short Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036390/
https://www.ncbi.nlm.nih.gov/pubmed/24872821
http://dx.doi.org/10.1186/1710-1492-10-23

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4036390/
https://www.ncbi.nlm.nih.gov/pubmed/24872821
http://dx.doi.org/10.1186/1710-1492-10-23

Ejemplares similares